Cargando…
Synthesis and Biological Evaluation of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of Oridonin as Potential Anti-Tumor Agents
To search for novel nitric oxide (NO) releasing anti-tumor agents, a series of novel furoxan/oridonin hybrids were designed and synthesized. Firstly, the nitrate/nitrite levels in the cell lysates were tested by a Griess assay and the results showed that these furoxan-based NO-releasing derivatives...
Autores principales: | Li, Dahong, Wang, Lei, Cai, Hao, Zhang, Yihua, Xu, Jinyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268409/ https://www.ncbi.nlm.nih.gov/pubmed/22710829 http://dx.doi.org/10.3390/molecules17067556 |
Ejemplares similares
-
Antitumor and Antibacterial Derivatives of Oridonin: A Main Composition of Dong-Ling-Cao
por: Li, Dahong, et al.
Publicado: (2016) -
Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound
por: Li, Dahong, et al.
Publicado: (2016) -
Design and synthesis of novel oridonin analogues as potent anticancer agents
por: Shen, Qing-Kun, et al.
Publicado: (2018) -
The potential of nitric oxide releasing therapies as antimicrobial agents
por: Schairer, David O., et al.
Publicado: (2012) -
Recent advances in oridonin derivatives with anticancer activity
por: Sobral, Pedro J. M., et al.
Publicado: (2023)